Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Index Funds median (375 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 20 Feb 2025 – 20 Aug 2026, limited by Kotak BSE Sensex Index Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Kotak BSE Sensex Index Fund | Nifty 50 |
|---|---|---|
| 20 Feb 2025 | ₹100.00 | ₹100.00 |
| 07 Apr 2025 | ₹96.66 | ₹96.72 |
| 22 May 2025 | ₹107.12 | ₹107.40 |
| 07 Jul 2025 | ₹110.96 | ₹111.12 |
| 21 Aug 2025 | ₹109.26 | ₹109.47 |
| 06 Oct 2025 | ₹108.96 | ₹109.45 |
| 20 Nov 2025 | ₹114.22 | ₹114.31 |
| 05 Jan 2026 | ₹113.95 | ₹114.56 |
| 19 Feb 2026 | ₹109.99 | ₹111.09 |
| 06 Apr 2026 | ₹98.82 | ₹100.24 |
| 21 May 2026 | ₹100.30 | ₹103.24 |
| 06 Jul 2026 | ₹104.84 | ₹106.62 |
| 20 Aug 2026 | ₹104.08 | ₹105.76 |
| Metric | Kotak Mahindra · Direct NAV ₹10.37 Very High risk ★☆☆☆☆ 1Y | Category median Index Funds · 375 funds |
|---|---|---|
| -4.58% | +5.66% | |
| — | +8.82% | |
| — | +9.15% | |
| — | +11.72% | |
| +2.71% | +7.67% | |
| -2.91% | — | |
| — | +12.67% | |
| — | +13.64% | |
| — | +12.84% | |
| Risk | ||
| 13.51% | 13.97% | |
| -0.82 | 0.24 | |
| -1.16 | 0.36 | |
| -16.12% | -16.12% | |
| Nifty 50 | — | |
| — | +0.84% | |
| — | 1.00 | |
| — | 102.2% | |
| — | 97.2% | |
| 0.32% | 0.36% | |
| ₹20.93Cr | ₹177.09Cr | |
| None | — | |
| None | — | |
| ₹100 | — | |
| ₹100 | — | |
| 36% | 35% | |
| Abhishek Bisen | — | |
| 20 Feb 2025 | — | |
| 30 | — | |
| 64.4% | — | |
| 0.3% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.